Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals

PLoS Computational Biology

Volumn 11, Issue 12, 2015, Pages

  Wang, Sunpeng ^a   Hottz, Patricia ^b   Schechter, Mauro ^b   Rong, Libin ^c  

^a NEW YORK UNIVERSITY   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DEATH; CELL PROLIFERATION; POPULATION STATISTICS;

CD4 T-CELLS; CELL MOVEMENT; CELL POPULATIONS; CYTOKINES; HIV INFECTION; HIV-1 INFECTIONS; INFLAMMATORY CYTOKINES; PROGRAMMED CELL DEATHS; T CELL DYNAMICS; TIME-SCALES;

T-CELLS;

ARTICLE; BRAZIL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL MEMBRANE PERMEABILITY; COMPUTER PREDICTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PROCESS MODEL; PYROPTOSIS; T CELL DEPLETION; VIRUS LATENCY; BIOLOGICAL MODEL; CD4 LYMPHOCYTE COUNT; CELL PROLIFERATION; COMPUTER SIMULATION; DISEASE COURSE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; PATHOLOGY;

CYTOKINE;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COMPUTER SIMULATION; CYTOKINES; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; MODELS, IMMUNOLOGICAL;

EID: 84953241375     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004665     Document Type: Article

References (78)

1. Epstein FH, Pantaleo G, Graziosi C, Fauci AS, (1993) The immunopathogenesis of human immunodeficiency virus infection. New Engl J Med 328: 327–335. 8093551
2. Fauci AS, Schnittman SM, Poli G, Koenig S, Pantaleo G, (1991) Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 114: 678–693. 1672248
3. Okoye AA, Picker LJ, (2013) CD4+ T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev 254: 54–64. doi: 10.1111/imr.12066 23772614
4. Quagliarello V, (1982) The Acquired Immunodeficiency Syndrome: current status. Yale J Biol Med 55: 443–452. 6134399
5. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, et al. (1981) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. New Engl J Med 305: 1425–1431. 6272109
6. Masur H, Michelis MA, Greene JB, Onorato I, Vande Stouwe RA, et al. (1981) An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. New Engl J Med 305: 1431–1438. 6975437
7. Muñoz A, Wang M-C, Bass S, Talyor JMG, Kingsley LA, et al. (1989) Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Am J Epidemiol 130: 530–539. 2669471
8. De Boer RJ, (2007) Time scales of CD4+ T cell depletion in HIV infection. PLoS Med 4: e193. 17518517
9. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, et al. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123–126. 7816094
10. Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD, (1998) Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 279: 1223–1227. 9469816
11. McCune JM, (2001) The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410: 974–979. 11309627
12. Okoye A, Meier-Schellersheim M, Brenchley JM, Hagen SI, Walker JM, et al. (2007) Progressive CD4+ central–memory T cell decline results in CD4+ effector–memory insufficiency and overt disease in chronic SIV infection. J Exp Med 204: 2171–2185. 17724130
13. Zeng M, Haase AT, Schacker TW, (2012) Lymphoid tissue structure and HIV-1 infection: life or death for T cells. Trends Immunol 33: 306–314. doi: 10.1016/j.it.2012.04.002 22613276
14. Zeng M, Paiardini M, Engram JC, Beilman GJ, Chipman JG, et al. (2012) Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution. Blood 120: 1856–1867. doi: 10.1182/blood-2012-03-418624 22613799
15. Matrajt L, Younan PM, Kiem H-P, Schiffer JT, (2014) The Majority of CD4+ T-Cell Depletion during Acute Simian-Human Immunodeficiency Virus SHIV89. 6P Infection Occurs in Uninfected Cells. J Virol 88: 3202–3212. doi: 10.1128/JVI.03428-13 24390339
16. Mohri H, Perelson AS, Tung K, Ribeiro RM, Ramratnam B, et al. (2001) Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med 194: 1277–1287. 11696593
17. Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, et al. (2001) Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med 194: 1731–1741. 11748275
18. Ribeiro RM, Mohri H, Ho DD, Perelson AS, (2002) In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted? Proc Natl Acad Sci U S A 99: 15572–15577. 12434018
19. Chan ML, Petravic J, Ortiz AM, Engram J, Paiardini M, et al. (2010) Limited CD4+ T cell proliferation leads to preservation of CD4+ T cell counts in SIV-infected sooty mangabeys. Proc Biol Sci 277: 3773–3781. doi: 10.1098/rspb.2010.0972 20591864
20. Yates A, Stark J, Klein N, Antia R, Callard R, (2007) Understanding the slow depletion of memory CD4+ T cells in HIV infection. PLoS Med 4: e177. 17518516
21. Hernandez-Vargas EA, Middleton RH, (2013) Modeling the three stages in HIV infection. J Theor Biol 320: 33–40. doi: 10.1016/j.jtbi.2012.11.028 23238280
22. Miao EA, Rajan JV, Aderem A, (2011) Caspase-1-induced pyroptotic cell death. Immunol Rev 243: 206–214. doi: 10.1111/j.1600-065X.2011.01044.x 21884178
23. Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, et al. (2014) Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505: 509–514. doi: 10.1038/nature12940 24356306
24. Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, et al. (2010) Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143: 789–801. doi: 10.1016/j.cell.2010.11.001 21111238
25. Djomand G, Duerr A, Faulhaber JC, Struchiner CJ, Pacheco AG, et al. (2006) Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 43: 401–404.
26. Harrison LH, do Lago RF, Friedman RK, Rodrigues J, Santos EM, et al. (1999) Incident HIV infection in a high-risk, homosexual, male cohort in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 21: 408–412.
27. Schechter M, do Lago RF, Mendelsohn AB, Moreira RI, Moulton LH, et al. (2004) Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immune Defic Syndr 35: 519–525.
28. Fidler S, Porter K, Ewings F, Frater J, Ramjee G, et al. (2013) Short-course antiretroviral therapy in primary HIV infection. New Engl J Med 368: 207–217. doi: 10.1056/NEJMoa1110039 23323897
29. Lyles RH, Muñoz A, Yamashita TE, Bazmi H, Detels R, et al. (2000) Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. J Infect Dis 181: 872–880. 10720507
30. Wang S, Rong L, (2014) Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy. J Theor Biol 360: 137–148. doi: 10.1016/j.jtbi.2014.06.042 25016044
31. Rong L, Perelson AS, (2009) Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy. PLoS Comput Biol 5: e1000533.
32. Rong L, Perelson AS, (2009) Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips. Math Biosci 217: 77–87. doi: 10.1016/j.mbs.2008.10.006 18977369
33. Rong L, Perelson AS, (2009) Modeling HIV persistence, the latent reservoir, and viral blips. J Theor Biol 260: 308–331. doi: 10.1016/j.jtbi.2009.06.011 19539630
34. Bofill M, Janossy G, Lee C, MacDonald-Burns D, Phillips A, et al. (1992) Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol 88: 243–252. 1349272
35. Perelson AS, Kirschner DE, De Boer R, (1993) Dynamics of HIV infection of CD4+ T cells. Math Biosci 114: 81–125. 8096155
36. Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, et al. (2003) A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol 77: 5037–5038. 12663814
37. Chen HY, Di Mascio M, Perelson AS, Ho DD, Zhang L, (2007) Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc Natl Acad Sci U S A 104: 19079–19084. 18025463
38. Hazuda D, Lee J, Young P, (1988) The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem 263: 8473–8479. 3259579
39. Efron B, Tibshirani R, (1986) Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Statist Sci: 54–75.
40. Silvestri G, Fedanov A, Germon S, Kozyr N, Kaiser WJ, et al. (2005) Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J Virol 79: 4043–4054. 15767406
41. Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, et al. (2003) Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18: 441–452. 12648460
42. Shedlock DJ, Silvestri G, Weiner DB, (2009) Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials. Nat Rev Immunol 9: 717–728. doi: 10.1038/nri2636 19859066
43. Rosenberg YJ, Janossy G, (1999) The importance of lymphocyte trafficking in regulating blood lymphocyte levels during HIV and SIV infections. Semin Immunol 11: 139–154. 10329500
44. Hengel RL, Jones BM, Kennedy MS, Hubbard MR, McDougal JS, (1999) Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans. J Immunol 163: 3539–3548. 10477629
45. Kirschner D, Webb G, Cloyd M, (2000) Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4+ lymphocytes. J Acquir Immune Defic Syndr 24: 352–362.
46. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, et al. (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359–362. 8096068
47. Collaboration ATC, (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372: 293–299. doi: 10.1016/S0140-6736(08)61113-7 18657708
48. Fang C, Chang Y, Hsu H, Twu S, Chen K-T, et al. (2007) Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM 100: 97–105. 17277317
49. Lloyd-Smith E, Brodkin E, Wood E, Kerr T, Tyndall MW, et al. (2006) Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS 20: 445–450. 16439879
50. May MT, Gompels M, Delpech V, Porter K, Orkin C, et al. (2014) Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS 28: 1193–1202.
51. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, et al. (2011) Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 155: 209–216. doi: 10.7326/0003-4819-155-4-201108160-00358 21768555
52. Geginat J, Sallusto F, Lanzavecchia A, (2001) Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells. J Exp Med 194: 1711–1719. 11748273
53. Bikker A, Erik Hack C, PJG Lafeber F, AG van Roon J, (2012) Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. Curr Pharm Des 18: 2347–2356. 22390698
54. Hartgring S, Willis CR, Bijlsma J, Lafeber F, van Roon J, (2012) Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation. Arthritis Res Ther 14: R137. doi: 10.1186/ar3870 22676399
55. Haase A, (1999) Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol 17: 625–656. 10358770
56. Nowak MA, Lloyd AL, Vasquez GM, Wiltrout TA, Wahl LM, et al. (1997) Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol 71: 7518–7525. 9311831
57. Chun T-W, Carruth L, Finzi D, Shen X, DiGiuseppe JA, et al. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183–188.
58. Harper ME, Marselle LM, Gallo RC, Wong-Staal F, (1986) Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci U S A 83: 772–776. 3003749
59. Nardelli B, Gonzalez CJ, Schechter M, Valentine FT, (1995) CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc Natl Acad Sci U S A 92: 7312–7316. 7638187
60. Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM, (2002) CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 169: 3400–3406. 12218162
61. Fleury S, Rizzardi G, Chapuis A, Tambussi G, Knabenhans C, et al. (2000) Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. Proc Natl Acad Sci U S A 97: 5393–5398. 10805798
62. Hellerstein M, Hanley M, Cesar D, Siler S, Papageorgopoulos C, et al. (1999) Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 5: 83–89. 9883844
63. Nash D, Katyal M, Brinkhof MW, Keiser O, May M, et al. (2008) Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS 22: 2291–2302. doi: 10.1097/QAD.0b013e3283121ca9 18981768
64. Osborn L, Hamann A, (1997) Endothelium and inflammation: Molecules and therapeutic prospects. In: Adhesion Molecules and Chemokines in Lymphocyte Trafficking Harwood. Academic Publishers. pp. 217–236.
65. Epstein FH, Gabay C, Kushner I, (1999) Acute-phase proteins and other systemic responses to inflammation. New Engl J Med 340: 448–454. 9971870
66. Kunkel EJ, Butcher EC, (2002) Chemokines and the tissue-specific migration of lymphocytes. Immunity 16: 1–4. 11825560
67. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG, (2006) Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126: 1135–1145. 16990137
68. Onder L, Narang P, Scandella E, Chai Q, Iolyeva M, et al. (2012) IL-7–producing stromal cells are critical for lymph node remodeling. Blood 120: 4675–4683. doi: 10.1182/blood-2012-03-416859 22955921
69. Malhotra D, Fletcher AL, Astarita J, Lukacs-Kornek V, Tayalia P, et al. (2012) Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol 13: 499–510. doi: 10.1038/ni.2262 22466668
70. Boxer MB, Quinn AM, Shen M, Jadhav A, Leister W, et al. (2010) A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety. ChemMedChem 5: 730–738. doi: 10.1002/cmdc.200900531 20229566
71. Randle JC, Harding MW, Ku G, Schönharting M, Kurrle R, (2001) ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs. Expert Opin Investig Drugs 10: 1207–1209. 11772244
72. Stack JH, Beaumont K, Larsen PD, Straley KS, Henkel GW, et al. (2005) IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J Immunol 175: 2630–2634. 16081838
73. Maroso M, Balosso S, Ravizza T, Iori V, Wright CI, et al. (2011) Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 8: 304–315. doi: 10.1007/s13311-011-0039-z 21431948
74. Vezzani A, Balosso S, Maroso M, Zardoni D, Noé F, et al. (2010) ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr Opin Investig Drugs 11: 43–50.
75. Fletcher CV, Staskus K, Wietgrefe SW, Rothenberger M, Reilly C, et al. (2014) Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A 111: 2307–2312. doi: 10.1073/pnas.1318249111 24469825
76. Rönsholt FF, Ullum H, Katzenstein TL, Gerstoft J, Ostrowski SR, (2013) Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy. PLoS ONE 8: e65182. doi: 10.1371/journal.pone.0065182 23755191
77. Sakaeda T, Nakamura T, Okumura K, (2004) Pharmacogenetics of drug transporters and its impact on the pharmacotherapy. Curr Top Med Chem 4: 1383–1398.
78. Löscher W, Potschka H, (2005) Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 76: 22–76. 16011870